Porcine pancreatic protease

Porcine pancreatic proteases, primarily comprising trypsin, chymotrypsin, and elastase, are essential digestive enzymes that catalyze the hydrolysis of dietary proteins into absorbable peptides and amino acids (StatPearls, 2023). These enzymes are secreted as zymogens by the exocrine pancreas and activated in the duodenum to facilitate nutrient absorption (UniProt, 2024). In clinical practice, porcine-derived pancreatic enzymes are the cornerstone of Pancreatic Enzyme Replacement Therapy (PERT), used to manage exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis, chronic pancreatitis, and pancreatectomy (NIH, 2023). While these enzymes serve as therapeutic replacements, they are also targets for inhibitors like aprotinin and camostat, which are used to mitigate autodigestion in conditions like acute pancreatitis (PubMed, 2022). The provided name "Dietary proteins and peptides – substrates of porcine pancreatic proteases" is technically a description of the biochemical substrates of these enzymes rather than a standard nomenclature for a single therapeutic target (ChEMBL, 2024).

Other names

Dietary proteins and peptides – substrates of porcine pancreatic proteasesPancreatic proteasesTrypsinChymotrypsinElastasePancreatinPancrelipaseSus scrofa pancreatic proteases

Exogenous enzyme replacement therapy to restore digestive capacity in the small intestine; Protease inhibition to prevent pancreatic autodigestion during inflammatory states.